Special Issue "Feature Papers of Cellular/Molecular Immunology"

A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Cellular/Molecular Immunology".

Deadline for manuscript submissions: 31 August 2022.

Special Issue Editor

Prof. Dr. Hans-Peter Hartung
E-Mail Website
Guest Editor
Department of Neurology, UKD, Center for Neurology and Neuropsychiatry, LVR Klinikum Heinrich-Heine-University Düsseldorf, Moorenstr. 5, 40225 Düsseldorf, Germany
Interests: regenerative therapies for inflammatory, ischemic and traumatic insults to the nervous system

Special Issue Information

Dear Colleagues,

As Section Editor-in-Chief of Cellular/Molecular Immunology, I am glad to announce the Special Issue "Feature Papers of Cellular/Molecular Immunology". This Special Issue is aim to enhance the impact of both basic immunology research and clinical applications. Spread the latest information and advancements in micro and macro immunological researches.

In this special issue, we will collect articles from top researchers describing new approaches or new cutting-edge developments in the fields of the immunological response of the host in vitro and in vivo, as well as in other relevant scientific fields. We welcome the submission of manuscripts from Editorial Board Members and from outstanding scholars invited by the Editorial Board and the Editorial Office.

You are welcome to send short proposals for submissions of Feature Papers to our Editorial Office (Va[email protected]) for evaluation.

Prof. Dr. Hans-Peter Hartung
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Published Papers

This special issue is now open for submission.
Back to TopTop